0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Multiple Sclerosis Therapeutics - Global Market Insights and Sales Trends 2024
Published Date: December 2023
|
Report Code: QYRE-Auto-11S14157
Home | Market Reports | Health| Health Foundations & Medical Research
Global Multiple Sclerosis Therapeutics Market Research Report 2023
BUY CHAPTERS

Multiple Sclerosis Therapeutics - Global Market Insights and Sales Trends 2024

Code: QYRE-Auto-11S14157
Report
December 2023
Pages:87
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Multiple Sclerosis Therapeutics - Market Size

The global Multiple Sclerosis Therapeutics market size is expected to reach US$ 19600 million by 2029, growing at a CAGR of 2.0% from 2023 to 2029.

Multiple Sclerosis Therapeutics -  Market

Multiple Sclerosis Therapeutics - Market

Multiple sclerosis (MS) is a potentially disabling disease of the brain and spinal cord (central nervous system). In MS, the immune system attacks the protective sheath (myelin) that covers nerve fibers and causes communication problems between your brain and the rest of your body. Eventually, the disease can cause the nerves themselves to deteriorate or become permanently damaged.
The market is mainly driven by the significant applications of Multiple Sclerosis Therapeutics in various end use industries. The expanding demands from the Hospital Pharmacies, Retail Pharmacies and e-Commerce,, are propelling Multiple Sclerosis Therapeutics market. Beta Interferon, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Corticosteroids segment is estimated at % CAGR for the next seven-year period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Objectives

This report provides market insight on the different segments, by players, by Type, by Distribution Channel. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Multiple Sclerosis Therapeutics, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.

Key Features of The Study:

This report provides in-depth analysis of the global Multiple Sclerosis Therapeutics market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Multiple Sclerosis Therapeutics market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Multiple Sclerosis Therapeutics sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Multiple Sclerosis Therapeutics covered in this report include Novartis, Teva Pharmaceuticals, Sanofi Genzyme, Bayer, Pfizer, Biogen Idec, Merck and AbbVie, etc.
The global Multiple Sclerosis Therapeutics market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Novartis
Teva Pharmaceuticals
Sanofi Genzyme
Bayer
Pfizer
Biogen Idec
Merck
AbbVie

Scope of Multiple Sclerosis Therapeutics - Market Report

Report Metric Details
Report Name Multiple Sclerosis Therapeutics - Market
Forecasted market size in 2029 US$ 19600 million
CAGR 2.0%
Forecasted years 2023 - 2029
Global Multiple Sclerosis Therapeutics market, by region:
  • North America (U.S., Canada, Mexico)
  • Europe (Germany, France, UK, Italy, etc.)
  • Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
  • South America (Brazil, etc.)
  • Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Multiple Sclerosis Therapeutics market, Segment by Type:
  • Beta Interferon
  • Corticosteroids
  • Monoclonal Antibodies
  • Antineoplastic Agents
  • Others
  • Global Multiple Sclerosis Therapeutics market, by Distribution Channel
  • Hospital Pharmacies
  • Retail Pharmacies
  • e-Commerce
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter Three: Provides the analysis of various market segments by Distribution Channel, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter Four: Detailed analysis of Multiple Sclerosis Therapeutics companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
  • Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
  • Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
  • Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter Twelve: Research Finding/Conclusion

FAQ for this report

What is the Multiple Sclerosis Therapeutics - Market size in 2029?

Ans: The Multiple Sclerosis Therapeutics - Market size in 2029 will be US$ 19600 million.

What are the Type segmentation covered in the Multiple Sclerosis Therapeutics - Market report?

Ans: The Types covered in the Multiple Sclerosis Therapeutics - Market report are Beta Interferon, Corticosteroids, Monoclonal Antibodies, Antineoplastic Agents, Others, Global Multiple Sclerosis Therapeutics market, by Distribution Channel, Hospital Pharmacies, Retail Pharmacies, e-Commerce

1 Market Overview of Multiple Sclerosis Therapeutics
1.1 Multiple Sclerosis Therapeutics Market Overview
1.1.1 Multiple Sclerosis Therapeutics Product Scope
1.1.2 Multiple Sclerosis Therapeutics Market Status and Outlook
1.2 Global Multiple Sclerosis Therapeutics Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Multiple Sclerosis Therapeutics Market Size by Region (2018-2029)
1.4 Global Multiple Sclerosis Therapeutics Historic Market Size by Region (2018-2023)
1.5 Global Multiple Sclerosis Therapeutics Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Multiple Sclerosis Therapeutics Market Size (2018-2029)
1.6.1 North America Multiple Sclerosis Therapeutics Market Size (2018-2029)
1.6.2 Europe Multiple Sclerosis Therapeutics Market Size (2018-2029)
1.6.3 Asia-Pacific Multiple Sclerosis Therapeutics Market Size (2018-2029)
1.6.4 Latin America Multiple Sclerosis Therapeutics Market Size (2018-2029)
1.6.5 Middle East & Africa Multiple Sclerosis Therapeutics Market Size (2018-2029)
2 Multiple Sclerosis Therapeutics Market by Type
2.1 Introduction
2.1.1 Beta Interferon
2.1.2 Corticosteroids
2.1.3 Monoclonal Antibodies
2.1.4 Antineoplastic Agents
2.1.5 Others
2.2 Global Multiple Sclerosis Therapeutics Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Multiple Sclerosis Therapeutics Historic Market Size by Type (2018-2023)
2.2.2 Global Multiple Sclerosis Therapeutics Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Multiple Sclerosis Therapeutics Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Multiple Sclerosis Therapeutics Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Multiple Sclerosis Therapeutics Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Multiple Sclerosis Therapeutics Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Multiple Sclerosis Therapeutics Revenue Breakdown by Type (2018-2029)
3 Multiple Sclerosis Therapeutics Market Overview by Distribution Channel
3.1 Introduction
3.1.1 Hospital Pharmacies
3.1.2 Retail Pharmacies
3.1.3 e-Commerce
3.2 Global Multiple Sclerosis Therapeutics Market Size by Distribution Channel: 2018 VS 2022 VS 2029
3.2.1 Global Multiple Sclerosis Therapeutics Historic Market Size by Distribution Channel (2018-2023)
3.2.2 Global Multiple Sclerosis Therapeutics Forecasted Market Size by Distribution Channel (2024-2029)
3.3 Key Regions Market Size by Distribution Channel
3.3.1 North America Multiple Sclerosis Therapeutics Revenue Breakdown by Distribution Channel (2018-2029)
3.3.2 Europe Multiple Sclerosis Therapeutics Revenue Breakdown by Distribution Channel (2018-2029)
3.3.3 Asia-Pacific Multiple Sclerosis Therapeutics Revenue Breakdown by Distribution Channel (2018-2029)
3.3.4 Latin America Multiple Sclerosis Therapeutics Revenue Breakdown by Distribution Channel (2018-2029)
3.3.5 Middle East and Africa Multiple Sclerosis Therapeutics Revenue Breakdown by Distribution Channel (2018-2029)
4 Multiple Sclerosis Therapeutics Competition Analysis by Players
4.1 Global Multiple Sclerosis Therapeutics Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Multiple Sclerosis Therapeutics as of 2022)
4.3 Date of Key Players Enter into Multiple Sclerosis Therapeutics Market
4.4 Global Top Players Multiple Sclerosis Therapeutics Headquarters and Area Served
4.5 Key Players Multiple Sclerosis Therapeutics Product Solution and Service
4.6 Competitive Status
4.6.1 Multiple Sclerosis Therapeutics Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Novartis
5.1.1 Novartis Profile
5.1.2 Novartis Main Business
5.1.3 Novartis Multiple Sclerosis Therapeutics Products, Services and Solutions
5.1.4 Novartis Multiple Sclerosis Therapeutics Revenue (US$ Million) & (2018-2023)
5.1.5 Novartis Recent Developments
5.2 Teva Pharmaceuticals
5.2.1 Teva Pharmaceuticals Profile
5.2.2 Teva Pharmaceuticals Main Business
5.2.3 Teva Pharmaceuticals Multiple Sclerosis Therapeutics Products, Services and Solutions
5.2.4 Teva Pharmaceuticals Multiple Sclerosis Therapeutics Revenue (US$ Million) & (2018-2023)
5.2.5 Teva Pharmaceuticals Recent Developments
5.3 Sanofi Genzyme
5.3.1 Sanofi Genzyme Profile
5.3.2 Sanofi Genzyme Main Business
5.3.3 Sanofi Genzyme Multiple Sclerosis Therapeutics Products, Services and Solutions
5.3.4 Sanofi Genzyme Multiple Sclerosis Therapeutics Revenue (US$ Million) & (2018-2023)
5.3.5 Bayer Recent Developments
5.4 Bayer
5.4.1 Bayer Profile
5.4.2 Bayer Main Business
5.4.3 Bayer Multiple Sclerosis Therapeutics Products, Services and Solutions
5.4.4 Bayer Multiple Sclerosis Therapeutics Revenue (US$ Million) & (2018-2023)
5.4.5 Bayer Recent Developments
5.5 Pfizer
5.5.1 Pfizer Profile
5.5.2 Pfizer Main Business
5.5.3 Pfizer Multiple Sclerosis Therapeutics Products, Services and Solutions
5.5.4 Pfizer Multiple Sclerosis Therapeutics Revenue (US$ Million) & (2018-2023)
5.5.5 Pfizer Recent Developments
5.6 Biogen Idec
5.6.1 Biogen Idec Profile
5.6.2 Biogen Idec Main Business
5.6.3 Biogen Idec Multiple Sclerosis Therapeutics Products, Services and Solutions
5.6.4 Biogen Idec Multiple Sclerosis Therapeutics Revenue (US$ Million) & (2018-2023)
5.6.5 Biogen Idec Recent Developments
5.7 Merck
5.7.1 Merck Profile
5.7.2 Merck Main Business
5.7.3 Merck Multiple Sclerosis Therapeutics Products, Services and Solutions
5.7.4 Merck Multiple Sclerosis Therapeutics Revenue (US$ Million) & (2018-2023)
5.7.5 Merck Recent Developments
5.8 AbbVie
5.8.1 AbbVie Profile
5.8.2 AbbVie Main Business
5.8.3 AbbVie Multiple Sclerosis Therapeutics Products, Services and Solutions
5.8.4 AbbVie Multiple Sclerosis Therapeutics Revenue (US$ Million) & (2018-2023)
5.8.5 AbbVie Recent Developments
6 North America
6.1 North America Multiple Sclerosis Therapeutics Market Size by Country (2018-2029)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe Multiple Sclerosis Therapeutics Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Multiple Sclerosis Therapeutics Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Multiple Sclerosis Therapeutics Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Multiple Sclerosis Therapeutics Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Multiple Sclerosis Therapeutics Market Dynamics
11.1 Multiple Sclerosis Therapeutics Industry Trends
11.2 Multiple Sclerosis Therapeutics Market Drivers
11.3 Multiple Sclerosis Therapeutics Market Challenges
11.4 Multiple Sclerosis Therapeutics Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
List of Tables
    Table 1. Global Market Multiple Sclerosis Therapeutics Market Size (US$ Million) Comparison by Region 2018 VS 2022 VS 2029
    Table 2. Global Multiple Sclerosis Therapeutics Market Size by Region (2018-2023) & (US$ Million)
    Table 3. Global Multiple Sclerosis Therapeutics Market Size Share by Region (2018-2023)
    Table 4. Global Multiple Sclerosis Therapeutics Forecasted Market Size by Region (2024-2029) & (US$ Million)
    Table 5. Global Multiple Sclerosis Therapeutics Forecasted Market Size Share by Region (2024-2029)
    Table 6. Global Multiple Sclerosis Therapeutics Market Size (US$ Million) by Type: 2018 VS 2022 VS 2029
    Table 7. Global Multiple Sclerosis Therapeutics Market Size by Type (2018-2023) & (US$ Million)
    Table 8. Global Multiple Sclerosis Therapeutics Revenue Market Share by Type (2018-2023)
    Table 9. Global Multiple Sclerosis Therapeutics Forecasted Market Size by Type (2024-2029) & (US$ Million)
    Table 10. Global Multiple Sclerosis Therapeutics Revenue Market Share by Type (2024-2029)
    Table 11. North America Multiple Sclerosis Therapeutics Revenue by Type (2018-2023) & (US$ Million)
    Table 12. North America Multiple Sclerosis Therapeutics Revenue by Type (2024-2029) & (US$ Million)
    Table 13. Europe Multiple Sclerosis Therapeutics Revenue by Type (2018-2023) & (US$ Million)
    Table 14. Europe Multiple Sclerosis Therapeutics Revenue by Type (2024-2029) & (US$ Million)
    Table 15. Asia-Pacific Multiple Sclerosis Therapeutics Revenue by Type (2018-2023) & (US$ Million)
    Table 16. Asia-Pacific Multiple Sclerosis Therapeutics Revenue by Type (2024-2029) & (US$ Million)
    Table 17. Latin America Multiple Sclerosis Therapeutics Revenue by Type (2018-2023) & (US$ Million)
    Table 18. Latin America Multiple Sclerosis Therapeutics Revenue by Type (2024-2029) & (US$ Million)
    Table 19. Middle East and Africa Multiple Sclerosis Therapeutics Revenue by Type (2018-2023) & (US$ Million)
    Table 20. Middle East and Africa Multiple Sclerosis Therapeutics Revenue by Type (2024-2029) & (US$ Million)
    Table 21. Global Multiple Sclerosis Therapeutics Market Size (US$ Million) by Distribution Channel: 2018 VS 2022 VS 2029
    Table 22. Global Multiple Sclerosis Therapeutics Market Size by Distribution Channel (2018-2023) & (US$ Million)
    Table 23. Global Multiple Sclerosis Therapeutics Revenue Market Share by Distribution Channel (2018-2023)
    Table 24. Global Multiple Sclerosis Therapeutics Forecasted Market Size by Distribution Channel (2024-2029) & (US$ Million)
    Table 25. Global Multiple Sclerosis Therapeutics Revenue Market Share by Distribution Channel (2024-2029)
    Table 26. North America Multiple Sclerosis Therapeutics Revenue by Distribution Channel (2018-2023) & (US$ Million)
    Table 27. North America Multiple Sclerosis Therapeutics Revenue by Distribution Channel (2024-2029) & (US$ Million)
    Table 28. Europe Multiple Sclerosis Therapeutics Revenue by Distribution Channel (2018-2023) & (US$ Million)
    Table 29. Europe Multiple Sclerosis Therapeutics Revenue by Distribution Channel (2024-2029) & (US$ Million)
    Table 30. Asia-Pacific Multiple Sclerosis Therapeutics Revenue by Distribution Channel (2018-2023) & (US$ Million)
    Table 31. Asia-Pacific Multiple Sclerosis Therapeutics Revenue by Distribution Channel (2024-2029) & (US$ Million)
    Table 32. Latin America Multiple Sclerosis Therapeutics Revenue by Distribution Channel (2018-2023) & (US$ Million)
    Table 33. Latin America Multiple Sclerosis Therapeutics Revenue by Distribution Channel (2024-2029) & (US$ Million)
    Table 34. Middle East and Africa Multiple Sclerosis Therapeutics Revenue by Distribution Channel (2018-2023) & (US$ Million)
    Table 35. Middle East and Africa Multiple Sclerosis Therapeutics Revenue by Distribution Channel (2024-2029) & (US$ Million)
    Table 36. Global Multiple Sclerosis Therapeutics Revenue (US$ Million) by Players (2018-2023)
    Table 37. Global Multiple Sclerosis Therapeutics Revenue Market Share by Players (2018-2023)
    Table 38. Global Top Players Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Multiple Sclerosis Therapeutics as of 2022)
    Table 39. Date of Key Players Enter into Multiple Sclerosis Therapeutics Market
    Table 40. Global Multiple Sclerosis Therapeutics Key Players Headquarters and Area Served
    Table 41. Multiple Sclerosis Therapeutics Product Solution and Service
    Table 42. Global Multiple Sclerosis Therapeutics Players Market Concentration Ratio (CR5 and HHI)
    Table 43. Mergers & Acquisitions, Expansion Plans
    Table 44. Novartis Basic Information List
    Table 45. Novartis Description and Business Overview
    Table 46. Novartis Multiple Sclerosis Therapeutics Products, Services and Solutions
    Table 47. Revenue (US$ Million) in Multiple Sclerosis Therapeutics Business of Novartis (2018-2023)
    Table 48. Novartis Recent Developments
    Table 49. Teva Pharmaceuticals Basic Information List
    Table 50. Teva Pharmaceuticals Description and Business Overview
    Table 51. Teva Pharmaceuticals Multiple Sclerosis Therapeutics Products, Services and Solutions
    Table 52. Revenue (US$ Million) in Multiple Sclerosis Therapeutics Business of Teva Pharmaceuticals (2018-2023)
    Table 53. Teva Pharmaceuticals Recent Developments
    Table 54. Sanofi Genzyme Basic Information List
    Table 55. Sanofi Genzyme Description and Business Overview
    Table 56. Sanofi Genzyme Multiple Sclerosis Therapeutics Products, Services and Solutions
    Table 57. Revenue (US$ Million) in Multiple Sclerosis Therapeutics Business of Sanofi Genzyme (2018-2023)
    Table 58. Sanofi Genzyme Recent Developments
    Table 59. Bayer Basic Information List
    Table 60. Bayer Description and Business Overview
    Table 61. Bayer Multiple Sclerosis Therapeutics Products, Services and Solutions
    Table 62. Revenue (US$ Million) in Multiple Sclerosis Therapeutics Business of Bayer (2018-2023)
    Table 63. Bayer Recent Developments
    Table 64. Pfizer Basic Information List
    Table 65. Pfizer Description and Business Overview
    Table 66. Pfizer Multiple Sclerosis Therapeutics Products, Services and Solutions
    Table 67. Revenue (US$ Million) in Multiple Sclerosis Therapeutics Business of Pfizer (2018-2023)
    Table 68. Pfizer Recent Developments
    Table 69. Biogen Idec Basic Information List
    Table 70. Biogen Idec Description and Business Overview
    Table 71. Biogen Idec Multiple Sclerosis Therapeutics Products, Services and Solutions
    Table 72. Revenue (US$ Million) in Multiple Sclerosis Therapeutics Business of Biogen Idec (2018-2023)
    Table 73. Biogen Idec Recent Developments
    Table 74. Merck Basic Information List
    Table 75. Merck Description and Business Overview
    Table 76. Merck Multiple Sclerosis Therapeutics Products, Services and Solutions
    Table 77. Revenue (US$ Million) in Multiple Sclerosis Therapeutics Business of Merck (2018-2023)
    Table 78. Merck Recent Developments
    Table 79. AbbVie Basic Information List
    Table 80. AbbVie Description and Business Overview
    Table 81. AbbVie Multiple Sclerosis Therapeutics Products, Services and Solutions
    Table 82. Revenue (US$ Million) in Multiple Sclerosis Therapeutics Business of AbbVie (2018-2023)
    Table 83. AbbVie Recent Developments
    Table 84. North America Multiple Sclerosis Therapeutics Market Size by Country (2018-2023) & (US$ Million)
    Table 85. North America Multiple Sclerosis Therapeutics Market Size by Country (2024-2029) & (US$ Million)
    Table 86. Europe Multiple Sclerosis Therapeutics Market Size by Country (2018-2023) & (US$ Million)
    Table 87. Europe Multiple Sclerosis Therapeutics Market Size by Country (2024-2029) & (US$ Million)
    Table 88. Asia-Pacific Multiple Sclerosis Therapeutics Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
    Table 89. Asia-Pacific Multiple Sclerosis Therapeutics Market Size by Region (2018-2023) & (US$ Million)
    Table 90. Asia-Pacific Multiple Sclerosis Therapeutics Market Size by Region (2024-2029) & (US$ Million)
    Table 91. Asia-Pacific Multiple Sclerosis Therapeutics Market Share by Region (2018-2023)
    Table 92. Asia-Pacific Multiple Sclerosis Therapeutics Market Share by Region (2024-2029)
    Table 93. Latin America Multiple Sclerosis Therapeutics Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
    Table 94. Latin America Multiple Sclerosis Therapeutics Market Size by Country (2018-2023) & (US$ Million)
    Table 95. Latin America Multiple Sclerosis Therapeutics Market Size by Country (2024-2029) & (US$ Million)
    Table 96. Middle East & Africa Multiple Sclerosis Therapeutics Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
    Table 97. Middle East & Africa Multiple Sclerosis Therapeutics Market Size by Country (2018-2023) & (US$ Million)
    Table 98. Middle East & Africa Multiple Sclerosis Therapeutics Market Size by Country (2024-2029) & (US$ Million)
    Table 99. Multiple Sclerosis Therapeutics Market Trends
    Table 100. Multiple Sclerosis Therapeutics Market Drivers
    Table 101. Multiple Sclerosis Therapeutics Market Challenges
    Table 102. Multiple Sclerosis Therapeutics Market Restraints
    Table 103. Research Programs/Design for This Report
    Table 104. Key Data Information from Secondary Sources
    Table 105. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Multiple Sclerosis Therapeutics Market Size Year-over-Year 2018-2029 & (US$ Million)
    Figure 2. Global Multiple Sclerosis Therapeutics Market Size (US$ Million), 2018 VS 2022 VS 2029
    Figure 3. Global Multiple Sclerosis Therapeutics Market Share by Regions: 2022 VS 2029
    Figure 4. Global Multiple Sclerosis Therapeutics Forecasted Market Size Share by Region (2024-2029)
    Figure 5. North America Multiple Sclerosis Therapeutics Market Size Growth Rate (2018-2029) & (US$ Million)
    Figure 6. Europe Multiple Sclerosis Therapeutics Market Size Growth Rate (2018-2029) & (US$ Million)
    Figure 7. Asia-Pacific Multiple Sclerosis Therapeutics Market Size Growth Rate (2018-2029) & (US$ Million)
    Figure 8. Latin America Multiple Sclerosis Therapeutics Market Size Growth Rate (2018-2029) & (US$ Million)
    Figure 9. Middle East & Africa Multiple Sclerosis Therapeutics Market Size Growth Rate (2018-2029) & (US$ Million)
    Figure 10. Product Picture of Beta Interferon
    Figure 11. Global Beta Interferon Market Size (US$ Million) & YoY Growth (2018-2029)
    Figure 12. Product Picture of Corticosteroids
    Figure 13. Global Corticosteroids Market Size (US$ Million) & YoY Growth (2018-2029)
    Figure 14. Product Picture of Monoclonal Antibodies
    Figure 15. Global Monoclonal Antibodies Market Size (US$ Million) & YoY Growth (2018-2029)
    Figure 16. Product Picture of Antineoplastic Agents
    Figure 17. Global Antineoplastic Agents Market Size (US$ Million) & YoY Growth (2018-2029)
    Figure 18. Product Picture of Others
    Figure 19. Global Others Market Size (US$ Million) & YoY Growth (2018-2029)
    Figure 20. Global Multiple Sclerosis Therapeutics Market Size Share by Type: 2022 & 2029
    Figure 21. North America Multiple Sclerosis Therapeutics Revenue Market Share by Type (2018-2029)
    Figure 22. Europe Multiple Sclerosis Therapeutics Revenue Market Share by Type (2018-2029)
    Figure 23. Asia-Pacific Multiple Sclerosis Therapeutics Revenue Market Share by Type (2018-2029)
    Figure 24. Latin America Multiple Sclerosis Therapeutics Revenue Market Share by Type (2018-2029)
    Figure 25. Middle East and Africa Multiple Sclerosis Therapeutics Revenue Market Share by Type (2018-2029)
    Figure 26. Hospital Pharmacies Market Size (US$ Million) & YoY Growth (2018-2029)
    Figure 27. Retail Pharmacies Market Size (US$ Million) & YoY Growth (2018-2029)
    Figure 28. e-Commerce Market Size (US$ Million) & YoY Growth (2018-2029)
    Figure 29. Global Multiple Sclerosis Therapeutics Market Size Share by Distribution Channel: 2022 & 2029
    Figure 30. North America Multiple Sclerosis Therapeutics Revenue Market Share by Distribution Channel (2018-2029)
    Figure 31. Europe Multiple Sclerosis Therapeutics Revenue Market Share by Distribution Channel (2018-2029)
    Figure 32. Asia-Pacific Multiple Sclerosis Therapeutics Revenue Market Share by Distribution Channel (2018-2029)
    Figure 33. Latin America Multiple Sclerosis Therapeutics Revenue Market Share by Distribution Channel (2018-2029)
    Figure 34. Middle East and Africa Multiple Sclerosis Therapeutics Revenue Market Share by Distribution Channel (2018-2029)
    Figure 35. Multiple Sclerosis Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022
    Figure 36. Global Top 5 and Top 10 Players Multiple Sclerosis Therapeutics Market Share in 2022
    Figure 37. North America Multiple Sclerosis Therapeutics Market Share by Country (2018-2029)
    Figure 38. U.S. Multiple Sclerosis Therapeutics Market Size (2018-2029) & (US$ Million)
    Figure 39. Canada Multiple Sclerosis Therapeutics Market Size (2018-2029) & (US$ Million)
    Figure 40. Germany Multiple Sclerosis Therapeutics Market Size (2018-2029) & (US$ Million)
    Figure 41. France Multiple Sclerosis Therapeutics Market Size (2018-2029) & (US$ Million)
    Figure 42. U.K. Multiple Sclerosis Therapeutics Market Size (2018-2029) & (US$ Million)
    Figure 43. Italy Multiple Sclerosis Therapeutics Market Size (2018-2029) & (US$ Million)
    Figure 44. Russia Multiple Sclerosis Therapeutics Market Size (2018-2029) & (US$ Million)
    Figure 45. Nordic Countries Multiple Sclerosis Therapeutics Market Size (2018-2029) & (US$ Million)
    Figure 46. Asia-Pacific Multiple Sclerosis Therapeutics Market Share by Region (2018-2029)
    Figure 47. China Multiple Sclerosis Therapeutics Market Size (2018-2029) & (US$ Million)
    Figure 48. Japan Multiple Sclerosis Therapeutics Market Size (2018-2029) & (US$ Million)
    Figure 49. South Korea Multiple Sclerosis Therapeutics Market Size (2018-2029) & (US$ Million)
    Figure 50. Southeast Asia Multiple Sclerosis Therapeutics Market Size (2018-2029) & (US$ Million)
    Figure 51. India Multiple Sclerosis Therapeutics Market Size (2018-2029) & (US$ Million)
    Figure 52. Australia Multiple Sclerosis Therapeutics Market Size (2018-2029) & (US$ Million)
    Figure 53. Latin America Multiple Sclerosis Therapeutics Market Share by Country (2018-2029)
    Figure 54. Mexico Multiple Sclerosis Therapeutics Market Size (2018-2029) & (US$ Million)
    Figure 55. Brazil Multiple Sclerosis Therapeutics Market Size (2018-2029) & (US$ Million)
    Figure 56. Middle East & Africa Multiple Sclerosis Therapeutics Market Share by Country (2018-2029)
    Figure 57. Turkey Multiple Sclerosis Therapeutics Market Size (2018-2029) & (US$ Million)
    Figure 58. Saudi Arabia Multiple Sclerosis Therapeutics Market Size (2018-2029) & (US$ Million)
    Figure 59. UAE Multiple Sclerosis Therapeutics Market Size (2018-2029) & (US$ Million)
    Figure 60. Bottom-up and Top-down Approaches for This Report
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$3350

This license allows only one user to access the PDF.
Electronic (PDF)

$5025

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$6700

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Seventh Sense AI

SIMILAR REPORTS